Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
REPLIDYNE, INC. (RDYN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: RDYN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Five Cheapest Stocks by Multiple Measures
Jason Kelly
•
Apr 29
•
2 Comments
Great Progress in Replidyne’s Pipeline
Adam Rubenstein
•
Feb 29
•
Comment!
Biotech Day in Review: Novartis Gets Approval for Hypertensive Drug Tekturna
Centient Biotech Investor
•
Mar 07
•
Comment!
Biotech Stocks Day-in-Review: IPOs Heat Up
Centient Biotech Investor
•
Feb 08
•
Comment!
2007: The Year Of Biotech IPOs?
Centient Biotech Investor
•
Jan 04
•
Comment!
This Week's IPOs Part II: Replidyne, Wintegra, Aventine Energy (RDYN, WNTG, AVR)
SA Editor Abbi Adest
•
Jun 25
•
Comment!
More articles on RDYN »
Sentiment
What advice would you give to
RDYN?
123 characters left
What's your view of RDYN?
Make sure you include RDYN
140 characters left
|
Settings